Executive Directory of the U. S. Pharmaceutical Industry
Author: Kenneth R. Kern
Publisher:
Published: 1976
Total Pages: 182
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author: Kenneth R. Kern
Publisher:
Published: 1976
Total Pages: 182
ISBN-13:
DOWNLOAD EBOOKAuthor: National Library of Medicine (U.S.)
Publisher:
Published: 1984
Total Pages: 1516
ISBN-13:
DOWNLOAD EBOOKA keyword listing of serial titles currently received by the National Library of Medicine.
Author: Congressional Budget Office
Publisher: Lulu.com
Published: 2013-06-09
Total Pages: 65
ISBN-13: 1304121445
DOWNLOAD EBOOKPerceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Author: United States. Congress. House. Commission on Information and Facilities
Publisher:
Published: 1976
Total Pages: 366
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
Published: 1969
Total Pages: 712
ISBN-13:
DOWNLOAD EBOOKAuthor: Charles Ralph Buncher
Publisher: CRC Press
Published: 1993-11-17
Total Pages: 606
ISBN-13: 9780824790738
DOWNLOAD EBOOKThis rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities
Publisher:
Published: 1967
Total Pages: 988
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Congress. House. Committee on the Judiciary
Publisher:
Published: 1962
Total Pages: 934
ISBN-13:
DOWNLOAD EBOOKAuthor: National Institute of Law Enforcement and Criminal Justice. Office of Technology Transfer
Publisher:
Published: 1972
Total Pages: 820
ISBN-13:
DOWNLOAD EBOOK